Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | EVM14 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on EVM14, a putative mRNA vaccine (Aug 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| EVM14 | EVM-14|EVM 14 | Limited information is currently available on EVM14, a putative mRNA vaccine (Aug 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07095868 | Phase Ib/II | EVM14 + Pembrolizumab EVM14 Pembrolizumab | Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors | Recruiting | USA | 1 |